Title
a. Authorize the Deputy Purchasing Agent for Natividad Medical Center (NMC) or his designee to execute an Agreement with Monarch Medical Technologies, LLC for glucose management system enterprise software subscription at NMC for an amount not to exceed $190,015 for the term October 1, 2018 through September 30, 2021.
b. Authorize the Deputy Purchasing Agent for NMC or his designee to execute up to three (3) future amendments to the agreement which do not significantly alter the scope of work and do not cause an increase of more than ten percent (10%) ($19,001) of the original cost of the agreement.
Report
RECOMMENDATION:
It is recommended the Board of Supervisors:
a. Authorize the Deputy Purchasing Agent for Natividad Medical Center (NMC) or his designee to execute an Agreement with Monarch Medical Technologies, LLC for glucose management system enterprise software subscription at NMC for an amount not to exceed $190,015 for the term October 1, 2018 through September 30, 2021.
b. Authorize the Deputy Purchasing Agent for NMC or his designee to execute up to three (3) future amendments to the agreement which do not significantly alter the scope of work and do not cause an increase of more than ten percent (10%) ($19,001) of the original cost of the agreement.
SUMMARY/DISCUSSION:
NMC's existing process for glucose control and insulin therapy management consists of multiple order sets for the provider to choose from and complicated protocols for nursing staff to follow. With the current non automated process glycemic control (hyper- and hypoglycemia) can be suboptimal.
Endotool is a clinical decision support software that integrates with MEDITECH providing personalized recommendations for insulin therapy to better control the patient's glycemic rates in a more automated fashion. The provider will no longer choose from multiple order sets but instead orders Endotool management. The nurse then follows the instructions from Endotool. The software is bu...
Click here for full text